Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- 最新申報
- 2026/8/13
2026 年第 1 季持倉
持倉截至 2026/3/31，2026/5/14 申報。只含多頭部位，變化是跟 2025 年第 4 季比股數。
- 持股檔數
- 95
- 較 2025 年第 4 季 +9
- 總值
- $17.1 億
- 較 2025 年第 4 季 +$3.13 億 (+22.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| APGEApogee Therapeutics, Inc. | COM | 1,284,926 | $1.08 億 | 6.3% | +50,000+4.0% | 加碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 1,675,000 | $9,740 萬 | 5.7% | +425,000+34.0% | 加碼 | 歷史 |
| ERASErasca, Inc. | COM | 5,350,000 | $8,656 萬 | 5.1% | +1,450,000+37.2% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 480,000 | $7,849 萬 | 4.6% | +30,000+6.7% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 2,800,000 | $7,756 萬 | 4.5% | +1,100,000+64.7% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,279,134 | $6,452 萬 | 3.8% | −153,457−10.7% | 減碼 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,400,000 | $5,561 萬 | 3.3% | +799,448+133.1% | 加碼 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 170,000 | $5,477 萬 | 3.2% | −15,000−8.1% | 減碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 940,000 | $5,213 萬 | 3.1% | +495,308+111.4% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 1,350,000 | $4,774 萬 | 2.8% | +350,000+35.0% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 700,483 | $4,617 萬 | 2.7% | −99,517−12.4% | 減碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 405,000 | $4,510 萬 | 2.6% | −100,000−19.8% | 減碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,400,000 | $4,217 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 362,764 | $4,165 萬 | 2.4% | −160,961−30.7% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 300,000 | $3,074 萬 | 1.8% | −22,633−7.0% | 減碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 562,631 | $2,966 萬 | 1.7% | +12,631+2.3% | 加碼 | 歷史 |
| DNTHDianthus Therapeutics, Inc. | COM | 350,000 | $2,937 萬 | 1.7% | +235,000+204.3% | 加碼 | 歷史 |
| LXEOLexeo Therapeutics, Inc. | COM | 5,050,211 | $2,899 萬 | 1.7% | +1,850,211+57.8% | 加碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 750,000 | $2,887 萬 | 1.7% | +400,000+114.3% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 55,000 | $2,879 萬 | 1.7% | +23,869+76.7% | 加碼 | 歷史 |
| STROSutro Biopharma, Inc. | COM SHS | 1,069,519 | $2,664 萬 | 1.6% | +321,137+42.9% | 加碼 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 1,011,890 | $2,621 萬 | 1.5% | +22,400+2.3% | 加碼 | 歷史 |
| ORKAOruka Therapeutics, Inc. | COM | 499,673 | $2,451 萬 | 1.4% | −302,669−37.7% | 減碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 2,000,172 | $2,386 萬 | 1.4% | −150,000−7.0% | 減碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 10,636,318 | $2,361 萬 | 1.4% | +3,486,318+48.8% | 加碼 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 586,904 | $2,301 萬 | 1.3% | +586,904 | 新進 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 95,000 | $2,173 萬 | 1.3% | +65,000+216.7% | 加碼 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 750,000 | $2,032 萬 | 1.2% | +20,000+2.7% | 加碼 | 歷史 |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 1,340,840 | $2,002 萬 | 1.2% | +289,786+27.6% | 加碼 | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 172,125 | $1,814 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 500,000 | $1,586 萬 | 0.9% | +150,000+42.9% | 加碼 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,564,303 | $1,526 萬 | 0.9% | +750,632+41.4% | 加碼 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 967,620 | $1,500 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| SVRASavara Inc | COM | 2,512,153 | $1,372 萬 | 0.8% | −285,000−10.2% | 減碼 | 歷史 |
| Omeros Corp682143AK8 | NOTE 9.500% 6/1 | – | $1,322 萬 | 0.8% | – | – | – |
| CATXPerspective Therapeutics, Inc. | COM NEW | 3,164,582 | $1,320 萬 | 0.8% | +2,864,582+954.9% | 加碼 | 歷史 |
| HLXCHelix Acquisition Corp. III | USD CL A ORD SHS | 1,250,000 | $1,270 萬 | 0.7% | +1,250,000 | 新進 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 200,000 | $1,254 萬 | 0.7% | +130,000+185.7% | 加碼 | 歷史 |
| DMRADamora Therapeutics, Inc. | COM NEW | 450,000 | $1,166 萬 | 0.7% | +450,000 | 新進 | 歷史 |
| EPRXEupraxia Pharmaceuticals Inc. | COM | 1,589,005 | $1,150 萬 | 0.7% | +1,289,005+429.7% | 加碼 | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 500,000 | $1,124 萬 | 0.7% | +500,000 | 新進 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 150,000 | $1,114 萬 | 0.7% | −170,000−53.1% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 781,260 | $1,110 萬 | 0.7% | −1,150,846−59.6% | 減碼 | 歷史 |
| BLTEBelite Bio, Inc | SPONSORED ADS | 65,000 | $1,036 萬 | 0.6% | +45,000+225.0% | 加碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 1,401,727 | $1,016 萬 | 0.6% | −1,298,273−48.1% | 減碼 | 歷史 |
| VERAVera Therapeutics, Inc. | CL A | 250,000 | $1,006 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 257,512 | $986.3 萬 | 0.6% | +257,512 | 新進 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 100,000 | $972.5 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| JBIOJade Biosciences, Inc. | COM NEW | 639,956 | $899.1 萬 | 0.5% | −75,000−10.5% | 減碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 300,000 | $891.3 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 275,000 | $880.3 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| Cogent Biosciences, Inc.19240QAA0 | NOTE 1.625%11/1 | – | $858.5 萬 | 0.5% | – | – | – |
| KRROKorro Bio, Inc. | COM | 706,904 | $800.2 萬 | 0.5% | +706,904 | 新進 | 歷史 |
| Celcuity Inc.15102KAA8 | NOTE 2.750% 8/0 | – | $731.4 萬 | 0.4% | – | – | – |
| CRSPCRISPR Therapeutics AG | NAMEN AKT | 150,000 | $713.5 萬 | 0.4% | +150,000 | 新進 | 歷史 |
| SGPSpyGlass Pharma, Inc. | COM SHS | 250,000 | $647.8 萬 | 0.4% | +250,000 | 新進 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 1,108,483 | $613.0 萬 | 0.4% | +908,483+454.2% | 加碼 | 歷史 |
| IBIOiBio, Inc. | COM NEW | 3,107,200 | $590.4 萬 | 0.3% | +1,050,000+51.0% | 加碼 | 歷史 |
| ESTAEstablishment Labs Holdings Inc. | COM | 100,000 | $567.8 萬 | 0.3% | −100,000−50.0% | 減碼 | 歷史 |
| AVRAnteris Technologies Global Corp. | COM | 912,397 | $506.4 萬 | 0.3% | +425,713+87.5% | 加碼 | 歷史 |
| NAMSWNewAmsterdam Pharma Co N.V. | *W EXP 11/22/202 | 245,000 | $491.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 250,000 | $489.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 700,000 | $479.5 萬 | 0.3% | −600,000−46.2% | 減碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,547,641 | $472.0 萬 | 0.3% | −803,503−34.2% | 減碼 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 868,020 | $453.5 萬 | 0.3% | −280,225−24.4% | 減碼 | 歷史 |
| MBXMBX Biosciences, Inc. | COM | 150,000 | $447.8 萬 | 0.3% | −100,000−40.0% | 減碼 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,000,000 | $447.0 萬 | 0.3% | −2,300,000−69.7% | 減碼 | 歷史 |
| MANEVeradermics, Inc | COMMON STOCK | 70,000 | $442.1 萬 | 0.3% | +70,000 | 新進 | 歷史 |
| GENBGenerate Biomedicines, Inc. | COM SHS | 350,000 | $437.5 萬 | 0.3% | +350,000 | 新進 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 610,370 | $415.7 萬 | 0.2% | −33,000−5.1% | 減碼 | 歷史 |
| AVBPArriVent BioPharma, Inc. | COM | 175,000 | $403.7 萬 | 0.2% | +25,000+16.7% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 400,000 | $398.0 萬 | 0.2% | +400,000 | 新進 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 2,454,278 | $397.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| VRCAVerrica Pharmaceuticals Inc. | COM SHS | 707,338 | $374.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| DTILPrecision Biosciences Inc | COM NEW | 597,946 | $328.9 萬 | 0.2% | +597,946 | 新進 | 歷史 |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 500,000 | $278.5 萬 | 0.2% | −389,575−43.8% | 減碼 | 歷史 |
| SLGLSol-Gel Technologies Ltd. | SHS NEW | 35,000 | $277.3 萬 | 0.2% | +35,000 | 新進 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 75,000 | $272.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| OACCUOaktree Acquisition Corp. III Life Sciences | UNIT 10/04/2029 | 250,000 | $266.3 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NXTCNextCure, Inc. | COM NEW | 241,826 | $258.3 萬 | 0.2% | −5,468−2.2% | 減碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 100,000 | $248.4 萬 | 0.1% | −100,000−50.0% | 減碼 | 歷史 |
| EQEquillium, Inc. | COM | 1,226,310 | $245.3 萬 | 0.1% | +1,226,310 | 新進 | 歷史 |
| SABSSAB Biotherapeutics, Inc. | COM NEW | 575,000 | $220.2 萬 | 0.1% | +575,000 | 新進 | 歷史 |
| CORTCorcept Therapeutics Inc | COM | 50,000 | $201.6 萬 | 0.1% | +50,000 | 新進 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | COM | 402,550 | $171.1 萬 | 0.1% | −170,254−29.7% | 減碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 229,076 | $170.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MGNXMacrogenics Inc | COM | 500,000 | $144.5 萬 | 0.1% | +15,692+3.2% | 加碼 | 歷史 |
| ANLAdlai Nortye Group Ltd. | ADS | 164,748 | $114.0 萬 | 0.1% | +164,748 | 新進 | 歷史 |
| ALECAlector, Inc. | COM | 500,000 | $107.5 萬 | 0.1% | +500,000 | 新進 | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 240,963 | $99.8 萬 | 0.1% | +240,963 | 新進 | 歷史 |
| LENZLENZ Therapeutics, Inc. | COM | 100,000 | $91.5 萬 | 0.1% | +100,000 | 新進 | 歷史 |
| XFORX4 Pharmaceuticals, Inc | COM NEW | 145,000 | $59.9 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| QTTBQ32 Bio Inc. | COM | 27,777 | $17.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ADGMAdagio Medical Holdings, Inc. | COM | 80,000 | $9.20 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Rocket Pharmaceuticals, Inc.77313F114 | *W EXP 09/02/202 | 75,000 | $1,178 | <0.1% | 00.0% | 不變 | – |
選擇權（10 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPYSPDR S&P 500 ETF Trust | ETF | $1.30 億 | – |
| MRNAModerna, Inc. | Stock | – | $4,064 萬 |
| BMYBristol Myers Squibb Co | Stock | – | $1,820 萬 |
| RVMDRevolution Medicines, Inc. | COM | $972.5 萬 | – |
| IBRXImmunityBio, Inc. | COM | $958.8 萬 | – |
| NVONovo Nordisk A S | ADR | – | $643.1 萬 |
| QUREuniQure N.V. | SHS | – | $490.5 萬 |
| DNTHDianthus Therapeutics, Inc. | COM | – | $419.6 萬 |
| CGONCG Oncology, Inc. | COM | – | $406.1 萬 |
| CELCCelcuity Inc. | COM | – | $342.4 萬 |
2025 年第 4 季之後清倉（11 檔）
2025 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 4 季股數 | 2025 年第 4 季市值 | 2025 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| VTYXVentyx Biosciences, Inc. | COM | 6,484,558 | $5,856 萬 | 4.2% | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $998.9 萬 | 0.7% | – |
| TNGXTango Therapeutics, Inc. | COM | 1,000,000 | $886.0 萬 | 0.6% | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 300,000 | $714.9 萬 | 0.5% | 歷史 |
| AVDLAvadel Pharmaceuticals PLC | Stock | 250,000 | $538.8 萬 | 0.4% | 歷史 |
| AMGNAmgen Inc | Stock | 10,000 | $327.3 萬 | 0.2% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COMMON STOCK | 100,000 | $289.3 萬 | 0.2% | 歷史 |
| GERNGeron Corp | COM | 1,500,000 | $198.0 萬 | 0.1% | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 75,000 | $172.5 萬 | 0.1% | 歷史 |
| QUREuniQure N.V. | SHS | 50,000 | $119.7 萬 | 0.1% | 歷史 |
| FRNMFreenome, Inc. | CL A ORD SHS | 50,000 | $65.2 萬 | <0.1% | 歷史 |